Ogilvie BW, Zhang D. et al. Glucuronidation converts gemfibrozil to a potent,
metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interac-
tions. Drug Metab Dispos 2006;34(1):191–197.
Pacifici GM, Coughtrie MWH. Human Cytosolic Sulfotransferases. Boca Raton FL:
CRC Press; 2005.
Park EY, Cho IJ, Kim SG. Transactivation of the PPAR-responsive enhancer module
in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-
activated receptor-gamma and retinoid X receptor heterodimer. Cancer Res
152004;64(10):3701–3713.
Pemble SE, Wardle AF, Taylor JB. Glutathione S-transferase class Kappa:
characterization by the cloning of rat mitochondrial GST and identification of a
human homologue. Biochem J Nov 11996;319(Pt 3):749–754.
Peters U, Preisler-Adams S, Hebeisen A. et al. Glutathione S-transferase genetic
polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.
Anticancer Drugs 2000;11(8):639–643.
Piirila P, Wikman H, Luukkonen R. et al. Glutathione S-transferase genotypes and
allergic responses to diisocyanate exposure. Pharmacogenetics 2001;11(5):437–
445.
Raftogianis RB, Her C. et al. Human phenol sulfotransferase pharmacogenetics: STP1
gene cloning and structural characterization. Pharmacogenetics 1996;6(6):473–487.
Raftogianis RB, Wood TC. et al. Human phenol sulfotransferases SULT1A2 and
SULT1A1:genetic polymorphisms, allozyme properties, and human liver genotype-
phenotype correlations. Biochem Pharmacol 1999;58(4):605–616.
Risch A, Wikman H, Thiel S. et al. Glutathione-S-transferase M1, M3, T1 and P1
polymorphisms and susceptibility to non-small-cell lung cancer subtypes and
hamartomas. Pharmacogenetics 2001;11(9):757–764.
Robbins PW, Lipmann F. Isolation and identification of active sulfate. J Biol Chem
1957;229(2):837–851.
Runge-Morris M, Rose K. et al. Regulation of rat hepatic sulfotransferase gene expression
by glucocorticoid hormones. Drug Metab Dispos 1996;24(10):1095–1101.
Runge-Morris M, Wu W. et al. Regulation of rat hepatic hydroxysteroid sulfo-
transferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual
mechanism of transcriptional control. Mol Pharmacol 1999;56(6):1198–1206.
Schuur AG, Legger FF. et al.In vitroinhibition of thyroid hormone sulfation by
hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol
1998;11(9):1075–1081.
Schramm VL, McCluskey R, Emig FA, Litwack G. Kinetic studies and active site-
binding properties of glutathione S-transferase using spin-labeled glutathione, a
product analogue. J Biol Chem 251984;259(2):714–722.
Seah VM, Wong KP. 2,6-Dichloro-4-nitrophenol (DCNP), an alternate-substrate
inhibitor of phenolsulfotransferase. Biochem Pharmacol 1994;47(10):1743–1749.
Shima N, Tsutsumi H. et al. Direct determination of glucuronide and sulfate of
p-hydroxymethamphetamine in methamphetamine users’ urine. J Chromatogr B
Analyt Technol Biomed Life Sci 2005.
Sohlenius-Sternbeck AK, Schmidt S. Impaired glutathione-conjugating capacity by
cryopreserved human and rat hepatocytes. Xenobiotica 2005;35(7):727–736.
REFERENCES 87